Literature DB >> 29283672

Measurement of the Retention Time of Different Ophthalmic Formulations with Ultrahigh-Resolution Optical Coherence Tomography.

Caterina Gagliano1,2,3, Vincenzo Papa4, Roberta Amato1, Giulia Malaguarnera1,2, Teresio Avitabile2.   

Abstract

Purpose/aim of the study: The purpose of this study was to measure the pre-corneal retention time of two marketed formulations (eye drops and eye gel) of a steroid-antibiotic fixed combination (FC) containing 0.1% dexamethasone and 0.3% netilmicin.
MATERIALS AND METHODS: Pre-corneal retention time was evaluated in 16 healthy subjects using an ultrahigh-resolution anterior segment spectral domain optical coherence tomography (OCT). All subjects randomly received both formulations of the FC (Netildex, SIFI, Italy). Central tear film thickness (CTFT) was measured before instillation (time 0) and then after 1, 10, 20, 30, 40 50, 60 and 120 min. The pre-corneal retention time was calculated by plotting CTFT as a function of time. Differences between time points and groups were analyzed by Student's t-test.
RESULTS: CTFT increased significantly after the instillation of the eye gel formulation (p < 0.001). CTFT reached its maximum value 1 min after instillation and returned to baseline after 60 min. No effect on CTFT was observed after the instillation of eye drops. The difference between the two formulations was statistically significant at time 1 min (p < 0.0001), 10 min (p < 0.001) and 20 min (p < 0.01).
CONCLUSIONS: The FC formulated as eye gel was retained on the ocular surface longer than the corresponding eye drop solution. Consequently, the use of the eye gel might extend the interval between instillations and decrease the frequency of administration.

Entities:  

Keywords:  OCT; Xanthan gum; dexamethasone; netilmicin; tear film thickness

Mesh:

Substances:

Year:  2017        PMID: 29283672     DOI: 10.1080/02713683.2017.1418893

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

1.  Reduced Posology of an Ophthalmic Hydrogel Containing Dexamethasone/Netilmicin to Prevent and Treat Ocular Inflammation After Cataract Surgery: Efficacy and Tolerability.

Authors:  Rita Mencucci; Thomas Ach; Anja Liekfeld; Antonio Scialdone; Claudine Civiale; Maria Grazia Mazzone; Aldo Caporossi
Journal:  Adv Ther       Date:  2022-10-07       Impact factor: 4.070

2.  Dexamethasone/Netilmicin Eye Drops and Eye Gel for the Treatment of Ocular Inflammation After Micro-Incisional Vitreoretinal Surgery.

Authors:  Antonio Rapisarda; Paolo Arpa; Paolo Maria Fantaguzzi; Francesco Faraldi; Roberto Ratiglia; Stanislao Rizzo; Paola Vaona; Claudio Iannacone; Vincenzo Papa
Journal:  Clin Ophthalmol       Date:  2020-10-14

3.  Assessment of a Cationic Emulsion to Control the Tear Film Evaporation Rate.

Authors:  Ali Abusharha
Journal:  Clin Optom (Auckl)       Date:  2021-08-11

4.  The use of preservatives in dry eye drops.

Authors:  Karen Walsh; Lyndon Jones
Journal:  Clin Ophthalmol       Date:  2019-08-01

Review 5.  The Emerging Role of Topical Ocular Drugs to Target the Posterior Eye.

Authors:  Lixiang Wang; Mikael Ben Zhou; Hui Zhang
Journal:  Ophthalmol Ther       Date:  2021-07-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.